Cory berkland.

Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.Cory Berkland Professor Biomedical Engineering [email protected] Google Scholar Education PhD, University of Illinois, 2003 MS, University of Illinois, 2001 BS, Iowa State University, 1998 Research areas Advanced Materials Biomedical, Bio-inspired, and Bio-derived Materials Cell & Molecular Bioengineering Regenerative Engineering in Medicine Pressnall MM, Huayamares SG, Berkland CJ. Immunostimulant Complexed with Polylysine Limits Transport and Maintains Immune Cell Activation. Journal of Pharmaceutical Sciences. PMID 32565351 DOI: 10.1016/j.xphs.2020.06.009 : 0.56: 2020: Griffin JD, Song JY, Sestak JO, DeKosky BJ, Berkland CJ. Linking autoantigen properties to mechanisms of immunity.Aug 2, 2016 · Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, Brantley-Sieders D, Cheng N. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat.

PRECLINICAL STUDY The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells Wei Bin Fang • Min Yao • Iman Jokar • Nabil Alhakamy • Cory Berkland • Jin Chen • Dana Brantley-Sieders • Nikki Cheng Received: 4 December 2014/Accepted: 24 February 2015/Published online: 6 March 2015

Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile . Jonathan Brumberg, Ph.D.-Associate Professor, Speech-Language-Hearing: Sciences & Disorders-Courtesy Associate Professor, Electrical Engineering & Computer Science;El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res. 2009; 26:1752-1763. [PMC free article] [Google Scholar] El-Gendy N, et al. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009; 98:2731-2746.

Cory's current address is 1300 Coconino Rd, Ames, IA. We know that one company — Mmc Photography, LLC — is registered at this address. We know that Julie M Anderson, Hyungjoo Choi, and 374 other persons also lived at this address, perhaps within a different time frame.Records show that Cory also lived at 802 Dickinson Ave, Ames, IA 50014.El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res. 2009; 26:1752-1763. [PMC free article] [Google Scholar] El-Gendy N, et al. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009; 98:2731-2746.Chittasupho C, Sestak J, Shannon L, Siahaan TJ, Vines CM, Berkland C. Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro. Mol Pharm. 2013;11(1):367-73. doi: 10.1021/mp4003909. [Europe PMC free article]Cory Berkland, Solon E. Summerfield Distinguished Professor in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering, is the fourth KU professor to earn the honor. ... Berkland joined KU in 2004, and his research blends engineering and biological sciences. As biotechnology improves methods for processes like tissue ...Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...

El-Gendy Nashwa, Huang Shan, Selvam Parthiban, Soni Pravin, Berkland Cory. Development of Budesonide NanoCluster Dry Powder Aerosols: Formulation and Stability. Journal of Pharmaceutical Sciences. 2012; 101 (9):3445-3455. [Google Scholar] 38. El-Gendy Nashwa, Huang Shan, Selvam Parthiban, Soni Pravin, Berkland Cory. ...

Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh ... Berkland: Bajoria, Sakashi: Volkin: Barreto, Layla: Volkin: Basra, Anil: Hageman:

Chad Groer, Ti Zhang, Ruolin Lu, Shuang Cai, Derek Mull, Aric Huang, Melanie Forrest, Cory Berkland, Daniel Aires, Marcus Laird Forrest Erythematous plaques on a tattoo. Atieh Jibbe, Vusala Snyder ...What We Do. Our lab works at the interface of medicine and engineering with an emphasis on precisely controlling the physical and chemical properties of particles and biomaterials. The lab environment fosters multidisciplinary interaction between graduate and undergraduate researchers from the departments of Chemical and Petroleum Engineering ... Gage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. 2020 Mar;39(11):2275-2289. doi: 10.1038/s41388-019-1141-7.TY - JOUR. T1 - Monodisperse liquid-filled biodegradable microcapsules. AU - Berkland, Cory. AU - Pollauf, Emily. AU - Varde, Neel. AU - Pack, Daniel W.TY - JOUR. T1 - Monodisperse liquid-filled biodegradable microcapsules. AU - Berkland, Cory. AU - Pollauf, Emily. AU - Varde, Neel. AU - Pack, Daniel W.

Cory Berkland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).Cory Berkland, Ph.D. Abstract Basic principles have emerged for oral and intravenous drug design, but fewer efforts have ... Berkland is a co-founder of Orbis Biosciences (purchased by Adare Pharmaceuticals), Savara Pharmaceuticals (NASDAQ: SVRA), Bond Biosciences, and Orion BioScience. Title: Microsoft Word - Cory Berkland Seminar Announcement ...Chittasupho C, Xie S-X, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. European Journal of Pharmaceutical Sciences. 2009; 37:141-150. [PMC free article] [Google Scholar]1. Introduction. The efficient delivery of therapeutic genes to a target site is a key to success in gene therapy. Viruses are very efficient gene vectors, but safety concerns such as immunogenicity of viral proteins and risk of oncogenesis still remain. 1 Non-viral vectors are continually under development and offer the potential for clinical application. 2 Cell penetrating peptides (CPPs ...1. INTRODUCTION. Hyaluronic acid (HA) is a linear biopolymer component of multiple approved products and exhibits versatility for drug delivery, since it is available in a wide range of molecular weights and offers multiple sites for chemical modification. 1–6 In the human body, HA is prevalent in cartilage, skin, and synovial fluid and is typically present as a very high molecular weight ...

Prof. Cory Berkland (Chair) Prof. Marylee Southard Prof. Stevin Gehrke Date Approved: iii Abstract: Magnetic nanoparticles that display high saturation magnetization and high magnetic susceptibility with a size less than 200 nm are of great interest for medical applications. Investigations of magnetic nanoparticles have been

INTRODUCTION. Investigations into the molecular processes involved in antigen recognition have led to new approaches in the design and administration of vaccines (1, 2).Traditionally, vaccines generate a robust immune response to a particular antigen by adsorbing the antigen to an alum particle surface (3-5).Though individual alum particles are quite small (10-50 nm), in solution they form ...Name: CORY BERKLAND Phone: (785) 864-1455 Email: [email protected]. Business Contact. Name: CORY BERKLAND Phone: (785) 764-0125 Email: [email protected]. Research Institution. N/A . Abstract. PROJECT SUMMARY/ABSTRACT Hereditary Hemochromatosis (HH) is one of the most common genetic disorders in the United …Cory Berkland. 2004, Biomaterials. Improved control of surface micro-and nano-structure may lead to enhanced performance of degradable biomedical devices such as surgical dressings, vascular grafts, tissue engineering scaffolds, sutures, and structures for guided tissue regeneration. An electrohydrodynamic method called flow-limited field ...Cory Berkland Magnetic nanoparticles that display high saturation magnetization and high magnetic susceptibility with a size less than 200 nm are of great interest for medical applications.As an alternative, nanoparticles may be targeted to a specific tissue with up-regulated cell adhesion molecules such as intercellular cell-adhesion molecule-1 (ICAM-1), which is dramatically up-regulated (~10 fold or more) on the vascular endothelium in response to the increased production of proinflammatory cytokines such as interleukin-1-β ...Cory Berkland The University of Kansas Verified email at ku.edu. Limin Wang rice university Verified email at rice.edu. ... MM Bailey, SR Kline, MD Anderson, JL Staymates, C Berkland. Journal of applied polymer science 126 (4), 1218-1227, 2012. 10: 2012: Fluorinated polymers and associated methods. C Berkland, M Bailey. US Patent App. 12/ ...Dec 29, 2017 · J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122. Name: CORY BERKLAND Phone: (785) 864-1455 Email: [email protected]. Business Contact. Name: CORY BERKLAND Phone: (785) 764-0125 Email: [email protected]. Research Institution. N/A . Abstract. PROJECT SUMMARY/ABSTRACT Hereditary Hemochromatosis (HH) is one of the most common genetic disorders in the United …Cory Berkland Date Defended: 11 July 2019. ii The thesis committee for Hao Lou certifies that this is the approved version of the following thesis: The Application of Machine Learning Algorithms in Understanding the Effect of Core/Shell Technique on Improving Powder CompactabilityI would like to sincerely and gratefully thank my advisor, Dr. Cory Berkland, for all of his support, guidance, patience, understanding, and most importantly, his friendship during my graduate studies at The University of Kansas. I have been fortunately blessed to have an advisor who gave me a great opportunity to develop my own individuality by

Cory J Berkland. Department of Chemical and Petroleum Engineering, University of Kansas, USA. Department of Pharmaceutical Chemistry, University of Kansas ...

The long-term objective of this application is to deliver a unique biomaterial that can easily be molded into place by a surgeon, and will resorb as it induces rapid tissue regeneration. Toward this o...

Dr. Cory Berkland Solon E. Summerfield Distinguished Professor School of Engineering, School of Pharmacy Chemical and Petroleum Engineering, Pharmaceutical Chemistry RESEARCH INTERESTS Antigen-specific immunotherapies, sequestering cells to combat autoimmunity, autoimmunity and tolerance reintroduction, targeted drug delivery, and gene delivery.1. Introduction. Fixed dose combinations (FDCs) are defined as a combination of two or more active ingredients within a single form of pharmaceutical administration [Citation 1 – Citation 6].They have been shown to appreciably reduce the risk of medication non-adherence, which is particularly important in patients with chronic diseases [Citation …Diaz is a scholar in the IMSD program and is mentored by Cory Berkland, Solon E. Summerfield Distinguished Professor. Jasmine Deng, of Shawnee, has a bachelor's degree in biochemistry from KU. Jasmine is a scholar in the PREP program and is mentored by Randolph Nudo, professor of molecular and integrative physiology, and Heather Hudson ...Cory Berkland. Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045. Search for more papers by this author. Stephen Johnson, Corresponding Author.ORCID record for Vivian Yudistyra. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities.Cory Berkland. The Berkland Lab investigates pharmaceuticals and biomaterials. They aim to understand the transport of pharmaceuticals as a function of physical and …Nov 11, 2011 · If delivered as a suspension, such small particles are also prone to particle growth due to Ostwald ripening and can suffer from uncontrolled agglomeration (Berkland, 2010). A major obstacle to inhaled therapeutics is the inability to efficiently deliver large quantities of a drug to the deep lung (Gillian, 2010). Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...Shara Thati, 1 Christopher Kuehl, 1 Brittany Hartwell, 2 Joshua Sestak, 1 Teruna Siahaan, 1 Laird Forrest, 1 and Cory Berkland 1, 3, * ... Davies NM, Berkland CJ, Forrest ML. Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer. International journal of pharmaceutics. 2010; 392 (1 ...Settimio Pacelli, Sayantani Basu, Jonathan Whitlow, Aparna Chakravarti, Francisca Acosta, Arushi Varshney, Saman Modaresi, Cory Berkland, Arghya Paul. Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration. Advanced Drug Delivery Reviews 2017, 120, 50-70. DOI: 10.1016/j.addr.2017.07.011.

Cory Berkland. Chemical & Petroleum Engineering, 1530 West 15th Street, University of Kansas, Lawrence, Kansas 66045-7609. Department of Pharmaceutical Chemistry, 2095 Constant Ave, University of Kansas, Lawrence, Kansas 66045-7609. Search for more papers by this authorTeruna, and Berkland Cory* Department of Pharmaceutical Chemistry, School of Pharmacy, The University of Kansas, Lawrence, Kansas, 66047 ... Kansas 66047 Phone: (785) 864-1455 Fax: (785) 864-1454 [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our ...Abdulgader A. Baoum1 and Cory J. Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS ... Baoum and Berkland Page 3 J Pharm Sci. Author manuscript; available in PMC 2014 October 23. NIH-PA Author Manuscript. gene delivery in vivo28,39-41. One approach for overcoming this limitation was to link theCory Berkland. The University of Kansas. ... CJ Berkland, ML Forrest. Advanced drug delivery reviews 61 (6), 457-466, 2009. 897: 2009: Nanotechnology in vaccine delivery.Instagram:https://instagram. davis cooper golfsurface integrals of vector fieldswild west trailers lubbockgeological epochs in order Cory . Berkland. Vladimir . Birman Associate Professor of Chemistry John . Bleeke Professor of Chemistry Robert . CharityCory Berkland [email protected] Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas … ku football score nowceltics heat box score What We Do. Our lab works at the interface of medicine and engineering with an emphasis on precisely controlling the physical and chemical properties of particles and biomaterials. The lab environment fosters multidisciplinary interaction between graduate and undergraduate researchers from the departments of Chemical and Petroleum Engineering ... INTRODUCTION. Multiple sclerosis (MS) is a neurodegenerative disease characterized by an inflammatory reaction against proteins in the central nervous system (CNS) leading to nervous system dysfunction and paralysis (1-3).Several FDA-approved therapies exist to treat patients with MS; however, these therapies do not cure the disease but rather are designed to slow disease progression and ... canterbury apartments muncie 1. Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev. 2008 May 22; 60(8):915–928. † We reviewed the field of nanotechnology applied to vaccine formulation and delivery in 2008. 2. O’Hagan DT, Fox CB. New generation adjuvants–from empiricism to rational design. Vaccine. 2015 Jun 8; 33(Suppl 2):B14 ...1. Introduction. Injectable scaffolds have received attention due to their potential for avoiding the invasive surgery typically required for tissue implantation. 1 From a clinical perspective, the use of injectable materials is an attractive alternative to surgery as it reduces the risk of infection, scar formation, patient discomfort and the cost of treatment. 2 Injectable scaffolds may be ...Three decades of promise have culminated in the development of gene therapies that can be applied to a broad range of human diseases. After a brief history, we provide an overview of gene therapy types and delivery methods, gene editing technologies, regulatory affairs, clinical trials, approved pro …